Accumulating evidence implicates visceral hypersensitivity, abnormal gastrointestinal motility, inflammation, and/or infection of the gut in its pathophysiology [53]
The GLP-1 RAs appear to modify atherosclerosis in the arteries, much like statin medications that treat cholesterol, and takes about a year or more to demonstrate measurable benefits on risk for cardiovascular events, whereas the SGLT2i medications seem to affect heart and kidney function more prominently and faster, with benefits evident very soon after starting the medication
A pilot study with metformin supplementation in 21 children and adolescents with PWS showed an improvement of the food-related distress and anxiety, evaluated by hyperphagia questionnaire, but no effects on body weight [19]
Information processing in the mammalian olfactory system
A 500mg formulation is considered a strong oral dosage in supplement form